125 related articles for article (PubMed ID: 15559875)
1. [Positron emission tomography (PET): a useful tool for the assessment of cardiac metabolism].
Alexánderson E; Gómez-Martín D; Benito I; Ruíz-Ramírez L; Ricalde A; Meave A
Arch Cardiol Mex; 2004; 74(3):220-8. PubMed ID: 15559875
[TBL] [Abstract][Full Text] [Related]
2. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
3. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
4. [Imaging of myocardial perfusion and metabolism with positron emission tomography].
Ishida Y; Fukuchi K; Oka M; Sagoh M; Miyake Y; Hasimoto N
Nihon Rinsho; 1998 Mar; 56(3):813-23. PubMed ID: 9549377
[TBL] [Abstract][Full Text] [Related]
5. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium.
Bergmann SR
J Nucl Med; 1994 Apr; 35(4 Suppl):15S-22S. PubMed ID: 8151408
[TBL] [Abstract][Full Text] [Related]
6. [Regional assessment of myocardial fatty acid metabolism by PET with 11C-palmitate].
Tamaki N; Kawamoto M; Tadamura E; Konishi J
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):629-35. PubMed ID: 12436593
[No Abstract] [Full Text] [Related]
7. Positron tomography and myocardial metabolism: an overview.
Sobel BE
Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
[No Abstract] [Full Text] [Related]
8. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids.
DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD
J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202
[TBL] [Abstract][Full Text] [Related]
9. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
Schelbert HR
Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
[No Abstract] [Full Text] [Related]
10. Cardiac positron tomography: current status and future directions.
Geltman EM; Roberts R; Sobel BE
Herz; 1980 Apr; 5(2):107-19. PubMed ID: 6970158
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac metabolism and perfusion evaluation in a rat model using 18F- FDG, 1-11C-acetate, 13NH3 and micro-positron emission tomography (microPET)].
Ojeda-Flores R; Ortega-López N; Ávila-Rodríguez MÁ; Trejo-Ballado F; Alexánderson-Rosas E
Arch Cardiol Mex; 2010; 80(4):215-28. PubMed ID: 21169085
[TBL] [Abstract][Full Text] [Related]
12. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
[TBL] [Abstract][Full Text] [Related]
13. [11C-acetate PET--evaluation of regional cardiac oxidative metabolism].
Nohara R
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):622-8. PubMed ID: 12436592
[No Abstract] [Full Text] [Related]
14. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
15. Time course of metabolic findings in coronary occlusion and reperfusion and their role for assessing myocardial salvage.
Schwaiger M
Eur J Nucl Med; 1986; 12 Suppl():S54-8. PubMed ID: 3490378
[TBL] [Abstract][Full Text] [Related]
16. Myocardial metabolic changes in hypertrophic cardiomyopathy.
Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
[TBL] [Abstract][Full Text] [Related]
18. 18F-deoxyglucose and the assessment of myocardial viability.
Schelbert HR
Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
[TBL] [Abstract][Full Text] [Related]
19. [Fatty acid metabolism using C-11 palmitate: (1). Resting study].
Tamaki N; Yonekura Y; Magata Y; Saji H; Fujibayashi Y; Sasayama S; Yamashita K; Ohtani H; Fujita T; Yamada T
Kaku Igaku; 1990 Apr; 27(4):313-21. PubMed ID: 2376917
[TBL] [Abstract][Full Text] [Related]
20. Quantitative FDG-uptake by positron emission tomography in progressive hypertrophy of rat hearts in vivo.
Handa N; Magata Y; Mukai T; Nishina T; Konishi J; Komeda M
Ann Nucl Med; 2007 Dec; 21(10):569-76. PubMed ID: 18092133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
